First Time Loading...

Imugene Ltd
ASX:IMU

Watchlist Manager
Imugene Ltd Logo
Imugene Ltd
ASX:IMU
Watchlist
Price: 0.085 AUD 1.19% Market Closed
Updated: May 2, 2024

Imugene Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imugene Ltd
Revenue Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Imugene Ltd
ASX:IMU
Revenue
AU$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Revenue
AU$256.6k
CAGR 3-Years
-61%
CAGR 5-Years
-45%
CAGR 10-Years
-24%
Mesoblast Ltd
ASX:MSB
Revenue
$7.5m
CAGR 3-Years
-23%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Revenue
$14.2B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
10%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Revenue
AU$87.3m
CAGR 3-Years
31%
CAGR 5-Years
25%
CAGR 10-Years
42%
Telix Pharmaceuticals Ltd
ASX:TLX
Revenue
AU$502.5m
CAGR 3-Years
359%
CAGR 5-Years
381%
CAGR 10-Years
N/A

See Also

What is Imugene Ltd's Revenue?
Revenue
0 AUD

Based on the financial report for Dec 31, 2023, Imugene Ltd's Revenue amounts to 0 AUD.